We serve Chemical Name:1,2,3,4,5-pentachloro-6-(chloromethyl)benzene CAS:2136-78-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1,2,3,4,5-pentachloro-6-(chloromethyl)benzene
CAS.NO:2136-78-9
Synonyms:Benzene,pentachloro(chloromethyl);Pentachlor-benzylchlorid;Pentachloro(chloromethyl)benzene;2.3.4.5.6-Pentachlor-1-chlormethyl-benzol;pentachloro-benzyl chloride
Molecular Formula:C7H2Cl6
Molecular Weight:298.80900
HS Code:2903999090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:339.3ºC at 760mmHg
Density:1.689g/cm3
Index of Refraction:1.599
PSA:
Exact Mass:295.82900
LogP:5.69240
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Benzene,pentachloro(chloromethyl) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,pentachloro-benzyl chloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Benzene,pentachloro(chloromethyl) Use and application,Pentachlor-benzylchlorid technical grade,usp/ep/jp grade.
Related News: Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology. 1,2,3,4,5-pentachloro-6-(chloromethyl)benzene manufacturer Large pharmaceutical companies are investing a disproportionately large amount of annual revenue in research and development (R&D), according to GlobalData��s Company Financials database. 1,2,3,4,5-pentachloro-6-(chloromethyl)benzene supplier Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology. 1,2,3,4,5-pentachloro-6-(chloromethyl)benzene vendor Large pharmaceutical companies are investing a disproportionately large amount of annual revenue in research and development (R&D), according to GlobalData��s Company Financials database. 1,2,3,4,5-pentachloro-6-(chloromethyl)benzene factory In addition, the FDA approval ignored the recommendation of its outside advisors, who said Biogen did not provide enough evidence of clinical benefit. Three of the advisory panel’s members have resigned in protest since the FDA decision was announced on Monday.
